Skip to main content

Table 1 Responses of carers to the COVID-19 lockdown survey questions

From: “I felt like I had been put on the shelf and forgotten about” – lasting lessons about the impact of COVID-19 on people affected by rarer dementias

 

Total

(N = 184)

 

bvFTD

(n = 62)

PCA

(n = 59)

PPA

(n = 36)

DLB

(n = 10)

fFTD

(n = 8)

fAD

(n = 3)

Other

(n = 6)

Questions about the person with dementia

         

Decline in cognitive symptoms

70%

 

66%

69%

72%

80%

75%

100%

67%

Negative impact on behaviour or wellbeing

57%

 

47%

64%

53%

70%

63%

100%

83%

Loss ability to do things

62%

 

55%

66%

50%

90%

88%

67%

83%

General health affected negatively

47%

 

38%

45%

53%

70%

71%

100%

67%

Medication changes†

26%

 

23%

29%

18%

50%

25%

0%

50%

Reduced ability to connect with people socially

71%

 

60%

78%

75%

90%

75%

67%

67%

Questions about the carer

         

Level of stress or health negatively impacted by the lockdown

79%

 

72%

80%

83%

90%

75%

100%

83%

Negative impact on support received for caring

55%*

 

52%

58%

58%

50%

40%

100%

50%

Harder for carer to provide care and support

93%**

 

92%

93%

67%

100%

100%

100%

100%

  1. *N = 144, including only carers of people living in the community
  2. **N = 40, including only carers of people living in care homes
  3. † increase or initiation of antidepressants, benzodiazepines, antipsychotics, “sleep medication” (as reported by respondents) and pain killers and in less frequently reported blood thinners, anticholinesterase inhibitors and beta blockers.
  4. Bold = 75% or more “yes” responses
  5. Underlined = 50–74% “yes” responses